FDA Guidance on PGx
	n PGx will “help individualize therapy with the intent of maximizing effectiveness and minimizing risk.” n Important “that FDA policy facilitate, not impede, the use of pharmacogenomic tests during drug development and, to the extent possible, encourage open and public sharing of data…on PGx test results.” n “most experimental results may not be well enough established to be suitable for regulatory decision making”